Healthcare provider profile · identity verified

Nichole Boisvert, MD

Family Practice · MARTINEZ, CA · NPI 1053726653

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	318	123
Amlodipine Besylate	Amlodipine Besylate	193	77
Gabapentin	Gabapentin	109	42
Metformin Hcl	Metformin Hcl	109	51
Albuterol Sulfate Hfa	Albuterol Sulfate	108	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	108	33
Lisinopril	Lisinopril	93	39
Omeprazole	Omeprazole	87	33
Jardiance	Empagliflozin	75	33
Losartan Potassium	Losartan Potassium	72	37
Metoprolol Succinate	Metoprolol Succinate	71	32
Mirtazapine	Mirtazapine	62	21
Famotidine	Famotidine	61	26
Fluticasone Propionate	Fluticasone Propionate	48	24
Levothyroxine Sodium	Levothyroxine Sodium	48	23
Ventolin Hfa	Albuterol Sulfate	48	16
Alendronate Sodium	Alendronate Sodium	40	14
Rybelsus	Semaglutide	39	15
Ozempic	Semaglutide	37	suppressed
Ibuprofen	Ibuprofen	36	19
Furosemide	Furosemide	35	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Carvedilol	Carvedilol	32	11
Hydrochlorothiazide	Hydrochlorothiazide	31	15
Diclofenac Sodium	Diclofenac Sodium	30	14
Naproxen	Naproxen	30	14
Sertraline Hcl	Sertraline Hcl	30	11
Anastrozole	Anastrozole	29	suppressed
Metformin Hcl Er	Metformin Hcl	29	16
Ezetimibe	Ezetimibe	28	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	28	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Potassium Chloride	Potassium Chloride	24	13
Rosuvastatin Calcium	Rosuvastatin Calcium	24	15
Trazodone Hcl	Trazodone Hcl	24	14
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Breyna	Budesonide/Formoterol Fumarate	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Finasteride	Finasteride	16	suppressed
Ibu	Ibuprofen	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Eliquis	Apixaban	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Simponi	Golimumab	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Risperidone	Risperidone	12	suppressed
Baclofen	Baclofen	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error